These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Mutational analysis of the TrkA gene in prostate cancer. George DJ, Suzuki H, Bova GS, Isaacs JT. Prostate; 1998 Aug 01; 36(3):172-80. PubMed ID: 9687989 [Abstract] [Full Text] [Related]
49. The trk family of tyrosine protein kinase receptors. Barbacid M, Lamballe F, Pulido D, Klein R. Biochim Biophys Acta; 1991 Dec 10; 1072(2-3):115-27. PubMed ID: 1751544 [No Abstract] [Full Text] [Related]
50. Activation of the receptor kinase domain of the trk oncogene by recombination with two different cellular sequences. Kozma SC, Redmond SM, Fu XC, Saurer SM, Groner B, Hynes NE. EMBO J; 1988 Jan 10; 7(1):147-54. PubMed ID: 2966065 [Abstract] [Full Text] [Related]
51. Frequent detection of TrkA expression in human neuroblastoma cell lines. Horii Y, Kuroda H, Sugimoto T. Acta Paediatr Jpn; 1998 Dec 10; 40(6):644-6. PubMed ID: 9893309 [No Abstract] [Full Text] [Related]
52. B-raf oncogene: activation by rearrangements and assignment to human chromosome 7. Kamiyama T, Aoki N, Yuasa Y. Jpn J Cancer Res; 1993 Mar 10; 84(3):250-6. PubMed ID: 8098025 [Abstract] [Full Text] [Related]
53. Non-secretory breast carcinomas lack NTRK rearrangements and TRK protein expression. Remoué A, Conan-Charlet V, Bourhis A, Flahec GL, Lambros L, Marcorelles P, Uguen A. Pathol Int; 2019 Feb 10; 69(2):94-96. PubMed ID: 30707464 [Abstract] [Full Text] [Related]
54. The genomic structure of the human UFO receptor. Schulz AS, Schleithoff L, Faust M, Bartram CR, Janssen JW. Oncogene; 1993 Feb 10; 8(2):509-13. PubMed ID: 8381225 [Abstract] [Full Text] [Related]
55. Structure and transforming potential of the human cot oncogene encoding a putative protein kinase. Miyoshi J, Higashi T, Mukai H, Ohuchi T, Kakunaga T. Mol Cell Biol; 1991 Aug 10; 11(8):4088-96. PubMed ID: 2072910 [Abstract] [Full Text] [Related]
56. Frequent generation of oncogenes by in vitro recombination of TRK protooncogene sequences. Oskam R, Coulier F, Ernst M, Martin-Zanca D, Barbacid M. Proc Natl Acad Sci U S A; 1988 May 10; 85(9):2964-8. PubMed ID: 3362859 [Abstract] [Full Text] [Related]
57. TRKing down an old oncogene in a new era of targeted therapy. Vaishnavi A, Le AT, Doebele RC. Cancer Discov; 2015 Jan 10; 5(1):25-34. PubMed ID: 25527197 [Abstract] [Full Text] [Related]
58. Analysis of the murine Dtk gene identifies conservation of genomic structure within a new receptor tyrosine kinase subfamily. Lewis PM, Crosier KE, Wood CR, Crosier PS. Genomics; 1996 Jan 01; 31(1):13-9. PubMed ID: 8808274 [Abstract] [Full Text] [Related]
59. Identification and characterization of a novel SCYL3-NTRK1 rearrangement in a colorectal cancer patient. Milione M, Ardini E, Christiansen J, Valtorta E, Veronese S, Bosotti R, Pellegrinelli A, Testi A, Pietrantonio F, Fucà G, Wei G, Murphy D, Siena S, Isacchi A, De Braud F. Oncotarget; 2017 Aug 15; 8(33):55353-55360. PubMed ID: 28903424 [Abstract] [Full Text] [Related]
60. Mechanism of activation of the human trk oncogene. Coulier F, Martin-Zanca D, Ernst M, Barbacid M. Mol Cell Biol; 1989 Jan 15; 9(1):15-23. PubMed ID: 2538716 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]